The outcome of 48 eyes with indirect traumatic optic neuropathy and periorbital facial bone fracture.
Dexter Y L
DY
Leung
Yolanda Y Y
YY
Kwong
Dennis S C
DS
Lam
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D019299:Decompression, Surgical; D004305:Dose-Response Relationship, Drug; D005147:Facial Bones / Q000293:injuries*; D005593:Fracture Fixation, Internal; D006801:Humans; D009408:Nerve Compression Syndromes / Q000628:therapy; D009901:Optic Nerve Diseases / Q000628:therapy; D020221:Optic Nerve Injuries / Q000628:therapy*; D009917:Orbital Fractures / Q000628:therapy*; D011183:Postoperative Complications / Q000209:etiology*; D012887:Skull Fractures / Q000628:therapy*; D014786:Vision Disorders / Q000209:etiology*; D014792:Visual Acuity; D014949:Wounds, Nonpenetrating / Q000628:therapy*
D000305:Adrenal Cortex Hormones